APVL SRL
APVL reported total assets of 96,516 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jun 2026).
The score of APVL shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APVL's annual accounts
| 2025 | |
|---|---|
| Net result | −38,473 € |
| Equity | −13,473 € |
| Cash | 9,999 € |
| EBITDA | −33,904 € |
| Total assets | 96,516 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
APVL's financial analysis
- Solvency-14.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APVL
APVL's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1014.898.429
- VAT number
- BE1014898429
- Peppol
- Registered · 0208:1014898429 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Oct 2024
- Registered office
- 2880 Bornem
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
APVL (SRL) has been based in Bornem since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 38,473 € and equity of −13,473 €; its revenue is not published. Its solvency stands at -14.0%, below the median of its sector (44.2%).
Companies similar to APVL
Companies in the same business, of comparable size and area, outside its group.
- Stelieco Retail sale of pharmaceutical products Brasschaat · balance sheet 96,802 €
- J. Veys Pharma Retail sale of pharmaceutical products Waregem · balance sheet 94,994 €
- Societe Pharmaceutique DE Gestion Retail sale of pharmaceutical products Ixelles · balance sheet 86,711 €
- Apotheek Verse Retail sale of pharmaceutical products Brussels · balance sheet 98,336 €
- Farmarie Retail sale of pharmaceutical products Destelbergen · balance sheet 94,659 €
- Arthur Pharma Retail sale of pharmaceutical products Zaventem · balance sheet 93,827 €
- S.G. Pharma Retail sale of pharmaceutical products Aalst · balance sheet 93,620 €
- Mencina Retail sale of pharmaceutical products Antwerp · balance sheet 99,620 €
Frequently asked questions about APVL
What is the revenue of APVL?
APVL files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APVL?
In Belgium, the VAT number is the company number prefixed with BE: BE1014898429 for APVL, if the company is VAT-registered. Its company number (CBE) is 1014.898.429.
Where is the registered office of APVL?
According to the CBE register, the registered office of APVL is in 2880 Bornem.
What is the equity of APVL?
At the close of the 2025 financial year, the equity of APVL amounts to -13,473 €, a solvency of -14.0% of total assets.
Who manages APVL?
The register lists 1 active mandates at APVL. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APVL
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →